Summary
Fetal dysrhythmias occur in a small percentage of all pregnancies. A subset of these dysrhythmias consist of brady- and tachycardia, which may cause serious morbidity and even mortality. Diagnosis at the earliest possible stage, understanding of its cause, recognition of its possible consequences and possible intra-uterine treatment of these dysrhythmias is crucial for the optimal treatment strategy. This article will focus on all aspects of fetal dysrhythmias, including new diagnostic techniques, recent developments in treatment and insights in the natural history of complete congenital heart block.
Samenvatting
Foetale hartritmestoornissen komen in een klein percentage van alle zwangerschappen voor. Brady- en tachycardieën kunnen ernstige morbiditeit en mortaliteit veroorzaken. Een vroege diagnose, begrip van de oorzaak, de mogelijke gevolgen en eventuele behandeling in utero van de hartritmestoornis zijn van belang voor een optimale aanpak. Dit artikel omschrijft de verschillende vormen van hartritmestoornissen in detail. Recente ontwikkelingen in nieuwe methoden van diagnose en nieuwe inzichten in behandeling komen aan bod.
Similar content being viewed by others
Literatuur
Bergmans MG, Jonker GJ, Kock HC. Fetal supraventricular tachycardia. Review of the literature. Obstet Gynecol Surv 1985;40:61-8.
Rooth G, Huch A, Huch R. Guidelines for the use of fetal monitoring. Int J Gynecol Obstet 1987;25:159.
Nijhuis IJM, Hof J ten, Mulder EJH, et al. Antenatal fetal heart rate monitoring; normograms and minimal duration of recordings. Prenat Neonat Med 1998;3:314-22.
Kleinman CS, Nehgme R, Copel JA, et al. Fetal cardiac arrhythmias: diagnosis and therapy. In: Creasy RK, Resnik R, eds. Matern-fetal medicine. Philadelphia: Saunders, 1998. p. 301-18.
Strasburger JF. Fetal arrhythmias. Prog Pediatr Cardiol 2000;11(1):1-17.
Quartero HW, Stinstra JG, Golbach EG, et al. Clinical implications of fetal magnetocardiography. Ultrasound Obstet Gynecol 2002;20(2):142-53.
Fouron JC, Proulx F, Miró J, Gosselin J. Doppler and M-mode ultrasonography to time fetal atrial and ventricular contractions. Obstet Gynecol 2000;96:732-6.
Fouron JC, Fournier A, Proulx F, et al. Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings. Heart 2003;89:1211-6.
Guntheroth WG, Cyr DR, Shields LE, Nghiem HV. Rate-based management of fetal supraventricular tachycardia. J Ultrasound Med 1996;15:453-8.
Naheed ZJ, Strasburger JF, Deal BJ, et al. Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 1996;27:1736-40.
Sonesson SE, Winberg P, Lidegran M, Westgren M. Foetal supraventricular tachycardia and cerebral complications. Acta Paediatr 1996;85:1249-52.
Schade RP, Stoutenbeek Ph, de Vries LS, Meijboom EJ. Neurological morbidity after fetal supraventricular tachyarrhythmia. Ultrasound Obstet Gynecol 1999;13:43-7.
Oudijk MA, Gooskens RHJM, Stoutenbeek Ph, et al. Neurological outcome of children who were treated for fetal tachycardia complicated by hydrops. Ultrasound Obstet Gynecol 2004;24:154-8.
Gest AL, Hansen TN, Moise AA, Hartley CJ. Atrial tachycardia causes hydrops in fetal lambs. Am J Physiol 1990;258: H1159-63.
Wladimiroff JW, Stewart PA. Treatment of fetal cardiac arrhythmias. Br J Hosp Med 1985;34:134-40.
Jouannic JM, Le Bidois J, Fermont L, et al. Prenatal ultrasound may predict fetal response to therapy in non-hydropic fetuses with supraventricular tachycardia. Fetal Diagn Ther 2002;17:120-3.
Oudijk MA. Fetal tachycardia, diagnosis and treatment, and the fetal QT interval in hypoxia [thesis]. Utrecht 2003.
Engelen AD van, Weijtens O, Brenner JI, et al. Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 1994;24:1371-5.
Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 1998;79:576-81.
Allan LD, Chita SK, Sharland GK, et al. Flecainide in the treatment of fetal tachycardias. Br Heart J 1991;65:46-8.
Krapp M, Baschat AA, Gembruch U, et al. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 2002;19:158-64.
Strasburger JF, Cuneo BF, Michon MM, et al. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 2004;109(3):375-9.
Oudijk MA, Michon MM, Kleinman CS, et al. Sotalol in the treatment of fetal dysrhythmias. Circulation 200;101:2721-6.
Oudijk MA, Ruskamp JM, Ververs FFT, et al. Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol 2003;42(4):765-70.
Anderson RH, Weninck ACG, Losekoot TG, Becker AE. Congenitally complete heart block: developmental aspects. Circulation 1977;56:90-101.
Chow LT, Cook AC, Ho SY, et al. Isolated congenitally complete heart block attributable to combined nodoventricular and intraventricular discontinuity. Hum Pathol 1998;29:729-36.
Michaelsson M, Engle MA. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin 1972;4:86-101.
Scott JS, Maddison PJ, Taylor PV, et al. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 1983;309:209-12.
Ramsey-Goldman R, Hom D, Deng J-S, et al. Anti SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 1988;31:697-701.
Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994;120:544-51.
Breur JMPJ, Kapusta L, Stoutenbeek P, et al. Isolated congenital atrioventricular block diagnosed in utero: natural history and outcome. Chapter 3 in Breur JMPJ. Fetal heart block [thesis]. Utrecht, 2003.
Udink ten Cate FEA, Breur JMPJ, Cohen MI, et al. Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children. J Am Coll Cardiol 2001;37:1129-34.
Buyon JP, Hiebert R, Copel JA, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-66.
Jaeggi E, Hamilton RM, Silverman ED, et al. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block: a single institution's experience of 30 years. J Am Coll Cardiol 2002;39:130-7.
Eronen M, Siren MK, Ekblad H, et al. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000;106:86-91.
Breur JMPJ, Gooskens RHJM, Kapusta L, et al. Neurological outcome of isolated congenital heart block diagnosed in utero, complicated by hydrops. Chapter 5 in Breur JMPJ. Fetal heart block [thesis]. Utrecht, 2003.
Kitridou RC. The neonatal lupus syndrome. In: Dubois' Lupus erythematosus. Philadelphia: Lippincott Williams & 38; Wilkins, 2002. Table 49-2.
Breur JMPJ, Visser GHA, Kruize AA, et al. Treatment of fetal heart block with maternal steroid therapy: case report and review of literature. Ultrasound Obstet Gynecol 2004;24(4):467-72.
Author information
Authors and Affiliations
Additional information
Dr. M.A. Oudijk, afdeling Obstetrie, Universitair Medisch Centrum Utrecht.
Correspondentieadres: Dr. M.A. Oudijk, afdeling Obstetrie, umcu, Postbus 85090, 3508 AB Utrecht.
Rights and permissions
About this article
Cite this article
Oudijk, M.A. Foetale hartritmestoornissen: recente ontwikkelingen. KIND 73, 110–117 (2005). https://doi.org/10.1007/BF03061557
Issue Date:
DOI: https://doi.org/10.1007/BF03061557